{"id":369823,"date":"2021-02-12T22:06:14","date_gmt":"2021-02-13T06:06:14","guid":{"rendered":"https:\/\/nai500.com\/blog\/2021\/02\/g1-therapeutics-jumps-16-9-as-trilaciclib-wins-fda-approval-bionano-genomics-shares-hit-all-time-high-spiking-nearly-23\/"},"modified":"2021-02-12T22:08:02","modified_gmt":"2021-02-13T06:08:02","slug":"%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e7%b2%be%e9%81%b8-g1-therapeutics-%e5%a4%a7%e6%bc%b2-bionano-genomics-%e8%82%a1%e5%83%b9%e5%89%b5%e6%ad%b7%e5%8f%b2%e6%96%b0%e9%ab%98","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2021\/02\/%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e7%b2%be%e9%81%b8-g1-therapeutics-%e5%a4%a7%e6%bc%b2-bionano-genomics-%e8%82%a1%e5%83%b9%e5%89%b5%e6%ad%b7%e5%8f%b2%e6%96%b0%e9%ab%98\/","title":{"rendered":"\u91ab\u7642\u4fdd\u5065\u7cbe\u9078\u2014\u2014G1 Therapeutics\u5927\u6f3216.9%\uff1bBionano Genomics\u80a1\u50f9\u5275\u6b77\u53f2\u65b0\u9ad8"},"content":{"rendered":"

G1 Therapeutics<\/strong>\u5927\u6f32<\/strong>16.9%<\/strong><\/h2>\n

G1 Therapeutics(NASDAQ:GTHX<\/a>)\u76e4\u5f8c\u5927\u6f3216.9%\uff0c\u6b64\u524dFDA\u6279\u51c6\u8a72\u516c\u53f8\u7684Cosela(trilaciclib)\u70ba\u540c\u985e\u7642\u6cd5\u4e2d\u9996\u500b “\u964d\u4f4e\u5ee3\u6cdb\u671f(\u7576\u764c\u75c7\u5df2\u64f4\u6563\u81f3\u80ba\u90e8\u4ee5\u5916)\u5c0f\u7d30\u80de\u80ba\u764c\u63a5\u53d7\u67d0\u4e9b\u985e\u578b\u5316\u7642\u7684\u6210\u5e74\u4eba\u5316\u7642\u5f15\u8d77\u7684\u9aa8\u9ad3\u6291\u5236\u983b\u7387”\u7684\u7642\u6cd5\u3002<\/p>\n

FDA\u8aaa\uff0cCosela\u53ef\u80fd\u901a\u904e\u6291\u5236\u7d30\u80de\u9031\u671f\u86cb\u767d\u4f9d\u8cf4\u6027\u6fc0\u91764\/6\uff08\u4e00\u7a2e\u9176\uff09\u4f86\u5e6b\u52a9\u4fdd\u8b77\u9aa8\u9ad3\u7d30\u80de\u514d\u53d7\u5316\u5b78\u7642\u6cd5\u7684\u640d\u5bb3\u3002<\/p>\n

Cosela\u7372\u5f97\u4e86FDA\u7684\u512a\u5148\u5be9\u67e5\u548c\u7a81\u7834\u6027\u7642\u6cd5\u7a31\u865f\u3002<\/p>\n

Bionano Genomics<\/strong>\u80a1\u50f9\u5275\u6b77\u53f2\u65b0\u9ad8<\/strong><\/h2>\n

Bionano Genomics\uff08NASDAQ:BNGO<\/a>\uff09\u7684\u80a1\u50f9\u4eca\u5929\u4e0b\u5348\u5275\u4e0b\u6b77\u53f2\u65b0\u9ad8\uff0c\u9996\u6b21\u7a81\u783414\u7f8e\u5143\u95dc\u53e3\u3002<\/p>\n

\u5728\u904e\u53bb\u768430\u5929\u88e1\uff0c\u80a1\u50f9\u5df2\u7d93\u7ffb\u4e86\u4e00\u500d\u591a\uff0c\u4e0a\u6f32\u4e86106%\u3002<\/p>\n

\u50c5\u4eca\u5929\u4e0b\u5348\u7684\u4ea4\u6613\u4e2d\uff0c\u80a1\u50f9\u5c31\u4e0a\u6f32\u4e8622.8%\u81f314.37\u7f8e\u5143\u3002<\/p>\n

\u4eca\u5929\u4e0a\u5348\u767c\u8868\u7684\u4e00\u7bc7\u6587\u7ae0\u8ac7\u5230\u4e86\u8a72\u516c\u53f8Saphyr\u57fa\u56e0\u7d44\u6210\u50cf\u7cfb\u7d71\u7684\u91cd\u8981\u6027\u3002<\/p>\n

\u6587\u7ae0\u8aaa\uff1a”\u7814\u7a76\u4eba\u54e1\u6b63\u5728\u4f7f\u7528Saphyr\u7cfb\u7d71\u4f86\u589e\u52a0\u4ed6\u5011\u5c0d\u4f7f\u67d0\u4e9b\u816b\u7624\u5177\u6709\u653b\u64ca\u6027\u7684\u57fa\u56e0\u7d44\u7d50\u69cb\u7684\u7406\u89e3\u3002\u901a\u904e\u9032\u884c\u9019\u6a23\u7684\u7814\u7a76\uff0c\u7814\u7a76\u4eba\u54e1\u5c07\u80fd\u5920\u958b\u767c\u51fa\u6709\u91dd\u5c0d\u6027\u7684\u7642\u6cd5\uff0c\u66f4\u597d\u5730\u5c0d\u764c\u75c7\u4e9e\u578b\u9032\u884c\u5206\u985e\uff0c\u4e26\u4f7f\u73fe\u6709\u7684\u764c\u75c7\u6cbb\u7642\u66f4\u52a0\u6709\u6548\u3002”<\/p>\n

\u4eca\u5e741\u6708\uff0cBionano\u80a1\u50f9\u66b4\u6f32\uff0c\u6b64\u524d\u767c\u8868\u7684\u4e00\u9805\u7814\u7a76\u986f\u793a\uff0cSaphyr\u7684\u5149\u5b78\u57fa\u56e0\u7d44\u5716\u8b5c\u767c\u73fe\u4e86\u7d50\u69cb\u8b8a\u7570\uff0c\u9019\u4e9b\u8b8a\u7570\u5f71\u97ff\u4e86\u63a7\u5236\u514d\u75ab\u548c\u708e\u75c7\u53cd\u61c9\u3001\u75c5\u6bd2\u7e41\u6b96\u548c\u7c98\u819c\u529f\u80fd\u7684\u9014\u5f91\u4e2d\u7684\u57fa\u56e0\uff0c\u9019\u53ef\u4ee5\u6709\u52a9\u65bc\u77ad\u89e3COVID-19\u7684\u767c\u75c5\u6a5f\u5236\u3002<\/p>\n

\u672c\u5468\u65e9\u4e9b\u6642\u5019\uff0c\u8a72\u516c\u53f8\u5831\u544a\u8aaa\uff0c\u591a\u502b\u591a\u7684\u5927\u5b78\u5065\u5eb7\u7db2\u7d61\u7684\u5be6\u9a57\u5ba4\u91ab\u5b78\u9805\u76ee\uff08\u52a0\u62ff\u5927\u6700\u5927\u7684\u91ab\u9662\u8a3a\u65b7\u6e2c\u8a66\u5be6\u9a57\u5ba4\uff09\u5df2\u7d93\u958b\u59cb\u8a66\u9edeSaphyr\u3002<\/p>\n

FDA<\/strong>\u6279\u51c6<\/strong>NantKwest<\/strong>\u64f4\u5927<\/strong>COVID-19<\/strong>\u75ab\u82d7\u7684<\/strong>1<\/strong>\u671f\u8a66\u9a57\uff0c\u80a1\u50f9\u5927\u6f32<\/strong><\/h2>\n

NantKwest, Inc. (NASDAQ:NK<\/a>)\u76e4\u524d\u4e0a\u6f3212.9%\uff0c\u6b64\u524d\u8a72\u516c\u53f8\u53ca\u5176\u79c1\u71df\u5408\u4f5c\u5925\u4f34ImmunityBio\u5ba3\u4f48FDA\u6279\u51c6\u64f4\u5927\u8a72\u516c\u53f8\u57fa\u65bcT\u7d30\u80de\u7684\u5019\u9078\u65b0\u51a0\u75ab\u82d7\u7684I\u671f\u7814\u7a76\u3002<\/p>\n

\u8a55\u4f30\u5be6\u9a57\u6027\u4e8c\u50f9hAd5 T\u7d30\u80de\u65b0\u51a0\u75c5\u6bd2\u76ae\u4e0b\u7248\u672c\u7684\u4e00\u671f\u8a66\u9a57\u7684C\u7d44\u8a66\u9a57\u5f97\u5230\u64f4\u5bb9\uff0c\u5c07\u589e\u52a0\u820c\u4e0b\u589e\u6548\u5291\u7684\u6548\u679c\u3002<\/p>\n

\u800c\u7b2c\u4e8c\u9805I\u671f\u7814\u7a76\u4e5f\u5c07\u958b\u59cb\u5728\u8a55\u4f30\u76ae\u4e0b\u539f\u6db2\u7d66\u85e5\u7684\u57fa\u790e\u4e0a\u589e\u52a0\u53e3\u670d\u589e\u6548\u5291\u7684\u6548\u679c\u3002<\/p>\n

\u6839\u64da\u4fee\u6539\u5f8c\u7684\u8a66\u9a57\uff0c\u516c\u53f8\u5c07\u78ba\u5b9a\u9069\u54082 \/ 3\u671f\u8a2d\u8a08\u7684\u6700\u4f73\u7d66\u85e5\u9014\u5f91\u548c\u5291\u91cf\u7d44\u5408\u3002<\/p>\n

\u8a72\u75ab\u82d7Ib\u671f\u3001\u958b\u653e\u6a19\u7c3d\u3001\u5291\u91cf\u7bc4\u570d\u7814\u7a76\u7684\u524d\u5169\u7d44\u53d7\u8a66\u8005\u63a5\u53d7\u5169\u7a2e\u4e0d\u540c\u5291\u91cf\uff080.5\u548c1\u6beb\u5347\uff09\u7684\u76ae\u4e0b\u6ce8\u5c04\uff0c\u9593\u969421\u5929\u3002<\/p>\n

\u53e6\u5916\u4e00\u7d44\u670940\u540d\u53d7\u8a66\u8005\uff0c\u4ee5\u8a55\u4f30\u5728\u56db\u500b\u4e0d\u540c\u7684\u5c0f\u7d44\u4e2d\u63a5\u53d7\u820c\u4e0b\u548c\u76ae\u4e0b\u88fd\u5291\u7684hAd5\u7d44\u5408\u7684\u7642\u6548\u3002<\/p>\n

\u7b2c\u4e8c\u98051b\u671f\u8a66\u9a57\u5c07\u662f\u4e00\u9805\u56db\u7d44\u968a\u5217\u7814\u7a76\uff0c\u9810\u8a08\u5c07\u65bc2021\u5e74\u7b2c\u4e00\u5b63\u5ea6\u958b\u59cb\uff0c\u53d7\u8a66\u8005\u591a\u905465\u4eba\u3002<\/p>\n

12\u6708\uff0cNantKwest\u5ba3\u4f48\u8207ImmunityBio\u9054\u6210\u5408\u4f75\u5354\u8b70\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

G1 Therapeutics\u5927\u6f3216.9% G1 Therapeutics(NASDAQ:GTHX)\u76e4\u5f8c\u5927\u6f32 […]<\/p>\n","protected":false},"author":9,"featured_media":369814,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[809,927,563,644,564],"class_list":["post-369823","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-809","tag-927","tag--zh-hant","tag-644","tag-564","sectors-life-science-zh-hant","locations-china-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant","exchange-nyse-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/369823","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=369823"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/369823\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/369814"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=369823"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=369823"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=369823"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}